About Us

The market size of rapid diagnostics reagents keeps increasing with the development of diagnostic machines while rapid diagnostics reagents had been used as supplementary and unaided eye diagnostic tools for first line disease diagnosis in the past.

Recently: high growth potentials for the rapid diagnostic reagent industry has been expected on a long term basis based on the fact that high technology for diagnosis in molecular level has contributed to the high costs in the medical industry.

Currently: Use of enzyme immunoassays, chemi-luminescence immunoassays and related reagents suitable for rapid testing and prescription on spot (POCT) diagnosis with a high accuracy of test results in molecular level.

In the Future: Complete low cost self diagnosis and management by high accuracy rapid diagnosis with at molecular level.

Below is General Information about AT First Diagnostic LLC.